Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Thyroid Eye Disease (TED) Market Grown from 2024 to 2025?
The market size for Thyroid Eye Disease (TED) has experienced robust growth in recent years, with a projection for its expansion from $2.15 billion in 2024 to $2.30 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 7.0%. The remarkable growth during the historic period has been a consequence of escalating thyroid disorders, a rising emphasis on care directed towards the patients, an increased desire for aesthetic procedures, a growing occurrence of the ailment, and a rise in the treatment alternatives for TED.
What Growth Rate Is Anticipated for the Thyroid Eye Disease (TED) Market in the Coming Years?
In the coming years, strong growth is projected for the Thyroid Eye Disease (TED) market. It is set to expand to $2.97 billion by 2029, with a compound annual growth rate (CAGR) of 6.6%. The growth during the forecast period can be correlated to the rising cases of Graves’ disease, enhanced funding across different industries, increased healthcare spending, growing utilization of thyroid hormone replacement therapy, along with an upward trend in thyroid disease incidents. The forecast period also highlights several significant trends, which includes technological progression, broadening R&D ventures, the creation of innovative drugs, improvements in treatment strategies, and emergence of new surgical methods.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21300&type=smp
Who Are the Leading Companies in the Thyroid Eye Disease (TED) Market?
Major companies operating in the thyroid eye disease (TED) market are Hoffmann-La Roche AG, Amgen Inc., Genentech Inc., Horizon Therapeutics plc, Pierre Fabre S.A., Innovent Biologics Inc., ACELYRIN Inc., Soleo Health, Zai Lab Limited, HanAll Biopharma Co. Ltd., Tourmaline Bio Inc., Zenas BioPharma Inc., Immunovant Inc., Verana Health, Harbour BioMed (Guangzhou) Co. Ltd., Sling Therapeutics Inc., Crinetics Pharmaceuticals Inc., Lassen Therapeutics Inc., Viridian Therapeutics Inc., Minghui Pharmaceutical Inc.
What Are the Key Drivers of the Thyroid Eye Disease (TED) Market?
An increase in thyroid-related ailments is anticipated to spur the expansion of the thyroid eye disease (TED) market. Medical conditions impacting the thyroid gland’s function, leading to hormonal imbalances and resulting in afflictions like hypothyroidism, hyperthyroidism, goiter, and thyroid eye disease fall under thyroid disorders. The rise in these disorders is attributed to heightened iodine consumption, autoimmune conditions, genetic influences, and an increase in awareness, leading to better diagnostic rates. Thyroid Eye Disease (TED), a prevalent and serious complication of Graves’ disease, adds to the surge in thyroid disorder cases, thereby heightening awareness and the overall task of managing thyroid-related conditions. As an illustration, the Canadian Cancer Society, a non-profit community organization based in Canada, predicted that about 6,600 new cases of thyroid cancer would be diagnosed in Canada in May 2024, leading to nearly 280 deaths. Consequently, the increasing incidence of thyroid disorders is fuelling the expansion of the thyroid eye disease (TED) market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21300&type=smp
What Are the Key Market Segments in the Thyroid Eye Disease (TED) Industry?
The thyroid eye disease (TED) market covered in this report is segmented –
1) By Treatment Type: Medical, Surgical, Combination Of Medical And Surgical
2) By Disease Severity: Mild, Moderate, Severe
3) By Drug Type: Biologics, Small Molecules, Others Drug Type
4) By Route Of Administration: Oral, Intravenous, Subcutaneous
5) By End User: Hospitals, Clinics, Other End Users
Subsegments:
1) By Medical: Corticosteroids, Teprotumumab, Antithyroid Medications, Other Medical Treatments
2) By Surgical: Orbital Decompression Surgery, Eyelid Surgery, Strabismus Surgery
3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression, Combination of Teprotumumab and Eyelid Surgery, Other Combined Approaches
What Are the Latest Trends in the Thyroid Eye Disease (TED) Market?
Leading corporations in the Thyroid Eye Disease (TED) market are directing their efforts towards the creation of innovative products like monoclonal antibody therapies. The aim is to generate more targeted, superior treatments that alleviate inflammation, ameliorate proptosis, and boost the overall patient results. Such therapies entail the use of synthetically crafted antibodies intended to mirror the immune system’s capability to pinpoint and neutralize specific pathogens or anomalous cells. For example, in September 2024, the United States biotechnology firm, Amgen Inc., disclosed that TEPEZZA (teprotumumab) had received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for the treatment of active Thyroid Eye Disease (TED). TED is a seldom occurrence but could potentially threaten vision and is an autoimmune disorder. It stands as the singular FDA-approved therapy designed specifically for TED that aids in reducing inflammation, swelling, and other severe symptoms linked to the disease. This authorization is of immense importance for Japanese patients as it introduces a fresh, operative alternative for handling TED – a scarce, advancing disorder that leads to painful eye protrusion, vision complications, and eye discomfort.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/thyroid-eye-disease-ted-global-market-report
What Are the Key Regional Markets in the Thyroid Eye Disease (TED) Industry?
North America was the largest region in the thyroid eye disease (TED) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid eye disease (TED) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21300
This Report Delivers Insight On:
1. How big is the thyroid eye disease (ted) market, and how is it changing globally?
2. Who are the major companies in the thyroid eye disease (ted) market, and how are they performing?
3. What are the key opportunities and risks in the thyroid eye disease (ted) market right now?
4. Which products or customer segments are growing the most in the thyroid eye disease (ted) market?
5. What factors are helping or slowing down the growth of the thyroid eye disease (ted) market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
